Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (16 OCT, 10.1038/s41591-023-02583-2, 2023 )

被引：0

作者：

Kirkwood, John M. ^{[1
]}

Del Vecchio, Michele ^{[2
]}

Weber, Jeffrey ^{[3
]}

Hoeller, Christoph ^{[4
]}

Grob, Jean-Jacques ^{[5
]}

Mohr, Peter ^{[6
]}

Loquai, Carmen ^{[7
]}

Dutriaux, Caroline ^{[8
]}

Chiarion-Sileni, Vanna ^{[9
]}

Mackiewicz, Jacek ^{[10
]}

Rutkowski, Piotr ^{[11
]}

Arenberger, Petr ^{[12
,13
]}

Quereux, Gaelle ^{[14
]}

Meniawy, Tarek M. ^{[15
,16
]}

Ascierto, Paolo A. ^{[17
]}

Menzies, Alexander M. ^{[18
,19
]}

Durani, Piyush ^{[20
]}

Lobo, Maurice ^{[20
]}

Campigotto, Federico ^{[20
]}

Gastman, Brian ^{[21
]}

Long, Georgina V. ^{[18
,19
]}

机构：

[1] UPMC, Hillman Canc Ctr, Pittsburgh, PA 15232 USA

[2] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[3] NYU, Langone Med Ctr, New York, NY USA

[4] Med Univ Wien, Vienna, Austria

[5] Hop La Timone, Marseille, France

[6] Elbe Klinikum Buxtehude, Buxtehude, Germany

[7] Univ Med Ctr Mainz, Mainz, Germany

[8] Hop St Andre, Bordeaux, France

[9] IOV IRCCS, Ist Oncol Veneto, Padua, Italy

[10] Poznan Univ Med Sci, Inst Oncol, Poznan, Poland

[11] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland

[12] Charles Univ Prague, Fac Med 3, Prague, Czech Republic

[13] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[14] Nantes Univ Hosp, Nantes, France

[15] Univ Western Australia, Perth, WA, Australia

[16] Sir Charles Gairdner Hosp, Perth, WA, Australia

[17] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy

[18] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia

[19] Royal North Shore & Mater Hosp, Sydney, NSW, Australia

[20] Bristol Myers Squibb, Princeton, NJ USA

[21] Cleveland Clin, Cleveland, OH USA

来源：

NATURE MEDICINE | 2023年 / 30卷 / 2期

关键词：

D O I：

10.1038/s41591-023-02661-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：607 / 607

页数：1